Modafinil, a potent suppressor in hepatocytes of CYP2C9, approved by FDA in treatment of narcolepsy [144], has been studied as a treatment option to overcome EDS and fatigue in patients with primary biliary cirrhosis [145,146]. The gene discussed is CYP2C9; the disease is primary biliary cholangitis.